Multicenter randomized phase III study of the cardioprotective effect of dexrazoxane (Cardioxane®) in advanced/metastatic breast cancer patients treated with anthracycline-based chemotherapy-Reference-Cited by-同舟云学术

Multicenter randomized phase III study of the cardioprotective effect of dexrazoxane (Cardioxane®) in advanced/metastatic breast cancer patients treated with anthracycline-based chemotherapy

Published:2006-04 Issue:4 Volume:17 Page:614-622
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Marty M.,Espié M.,Llombart A.,Monnier A.,Rapoport B.L.,Stahalova V.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/17/4/614/685112/mdj134.pdf

Reference31 articles.

1. Predictive value of cardiac troponin T in pediatric patients at risk for myocardial injury;Lipshultz;Circulation,1997

2. A comparison of cardiac biopsy grades and ejection fraction estimations in patients receiving adriamycin;Ewer;J Clin Oncol,1984

3. Protective effect of the bispiperazinedione ICRF-187 against doxorubicin-induced cardiac toxicity in women with advanced breast cancer;Speyer;N Engl J Med,1988

4. ICRF-187 permits longer treatment with doxorubicin in women with breast cancer;Speyer;J Clin Oncol,1992

5. Risk factors for doxorubicin-induced congestive heart failure;Von Hoff;Ann Intern Med,1979

Cited by 177 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evolving therapeutics and ensuing cardiotoxicities in triple-negative breast cancer;Cancer Treatment Reviews;2024-11

2. Prevention of Anthracyclines and HER2 Inhibitor-Induced Cardiotoxicity: A Systematic Review and Meta-Analysis;Cancers;2024-06-30

3. An update of the molecular mechanisms underlying anthracycline induced cardiotoxicity;Frontiers in Pharmacology;2024-06-26

4. Molecular Mechanisms and Therapeutic Targeting of Ferroptosis in Doxorubicin-Induced Cardiotoxicity;JACC: Basic to Translational Science;2024-06

5. Cardiomyocytes, cardiac endothelial cells and fibroblasts contribute to anthracycline-induced cardiac injury through RAS-homologous small GTPases RAC1 and CDC42;Pharmacological Research;2024-05